Cormorant Asset Management, LP 13D/13G Filings for Atea Pharmaceuticals, Inc. (AVIR)

Cormorant Asset Management, LP 13D and 13G filings for Atea Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
3:05 pm
Sale
2021-12-3113GATEA PHARMACEUTICALS INC
AVIR
Cormorant Asset Management, LP1,679,442
2.020%
-4,731,913decrease
(-73.81%)
Filing